ACLX

Arcellx, Inc.

Biological Products, (No Diagnostic Substances)NasdaqLarge accelerated filer

Total Trades

138

Buys

5

Sells

77

Largest Trade

N/A

Insiders

14

Institutional Funds

170

Inst. Value

$1M+

Activist Filings

50

Insider Trades

InsiderTitleTypeValueSharesPriceDate
Heery ChristopherCHIEF MEDICAL OFFI…EXERCISEN/A30KJan 7, 2025
Elghandour RamiSEE REMARKSSELL$1M+29K$78.40Jan 7, 2025
Elghandour RamiSEE REMARKSEXERCISEN/A109KJan 7, 2025
Patel KavitaDirectorSELL$100K–$500K2K$76.97Dec 27, 2024
Patel KavitaDirectorEXERCISE$1K–$15K2K$6.66Dec 27, 2024
Gilson MichelleCHIEF FINANCIAL OF…EXERCISE$15K–$50K3K$8.66Nov 19, 2024
Gilson MichelleCHIEF FINANCIAL OF…SELL$100K–$500K2K$88.87Nov 19, 2024
Patel KavitaDirectorSELL$100K–$500K2K$106.33Nov 14, 2024
Patel KavitaDirectorEXERCISE$1K–$15K2K$6.66Nov 14, 2024
Gilson MichelleCHIEF FINANCIAL OF…SELL$1M+12K$100.55Nov 13, 2024
Gilson MichelleCHIEF FINANCIAL OF…EXERCISE$50K–$100K7K$8.66Nov 13, 2024
Patel KavitaDirectorEXERCISE$500K+57K$12.61Nov 13, 2024
Patel KavitaDirectorSELL$1M+57K$103.90Nov 13, 2024
Patel KavitaDirectorEXERCISE$1K–$15K2K$6.66Oct 22, 2024
Patel KavitaDirectorSELL$100K–$500K2K$89.69Oct 22, 2024
Patel KavitaDirectorSELL$100K–$500K2K$82.24Oct 3, 2024
Patel KavitaDirectorEXERCISE$1K–$15K2K$6.66Oct 3, 2024
Heery ChristopherCHIEF MEDICAL OFFI…SELL$1M+27K$67.03Sep 4, 2024
Heery ChristopherCHIEF MEDICAL OFFI…EXERCISE$100K–$500K27K$13.27Sep 4, 2024
Heery ChristopherCHIEF MEDICAL OFFI…EXERCISE$100K–$500K22K$15.00Aug 28, 2024
Heery ChristopherCHIEF MEDICAL OFFI…SELL$1M+22K$71.13Aug 28, 2024
Patel KavitaDirectorEXERCISE$1K–$15K2K$6.66Aug 22, 2024
Patel KavitaDirectorSELL$50K–$100K2K$65.88Aug 22, 2024
Heery ChristopherCHIEF MEDICAL OFFI…EXERCISE$15K–$50K5K$6.28Aug 19, 2024
Heery ChristopherCHIEF MEDICAL OFFI…SELL$100K–$500K5K$65.05Aug 19, 2024
Heery ChristopherCHIEF MEDICAL OFFI…EXERCISE$100K–$500K20K$10.94Aug 2, 2024
Heery ChristopherCHIEF MEDICAL OFFI…SELL$1M+20K$60.42Aug 2, 2024
Patel KavitaDirectorSELL$50K–$100K2K$61.97Aug 1, 2024
Patel KavitaDirectorEXERCISE$1K–$15K2K$6.66Aug 1, 2024
Heery ChristopherCHIEF MEDICAL OFFI…EXERCISE$100K–$500K20K$11.93Jul 3, 2024
Heery ChristopherCHIEF MEDICAL OFFI…SELL$1M+20K$55.39Jul 3, 2024
Patel KavitaDirectorSELL$500K+10K$54.27Jun 28, 2024
Patel KavitaDirectorEXERCISE$50K–$100K10K$6.66Jun 28, 2024
Gilson MichelleCHIEF FINANCIAL OF…SELL$500K+13K$53.70Jun 28, 2024
Heery ChristopherCHIEF MEDICAL OFFI…EXERCISE$100K–$500K20K$11.53Jun 14, 2024
Heery ChristopherCHIEF MEDICAL OFFI…SELL$1M+20K$55.13Jun 14, 2024
Gilson MichelleCHIEF FINANCIAL OF…SELL$500K+12K$50.71May 25, 2024
Gilson MichelleCHIEF FINANCIAL OF…EXERCISEN/A22KMay 25, 2024
Heery ChristopherCHIEF MEDICAL OFFI…SELL$500K+18K$51.33May 3, 2024
Heery ChristopherCHIEF MEDICAL OFFI…EXERCISE$100K–$500K18K$6.28May 3, 2024
Ware Olivia CDirectorEXERCISE$50K–$100K9K$7.61Apr 18, 2024
Ware Olivia CDirectorSELL$500K+9K$55.55Apr 18, 2024
Elghandour RamiSEE REMARKSSELL$1M+23K$67.09Apr 3, 2024
Heery ChristopherCHIEF MEDICAL OFFI…SELL$1M+47K$70.06Mar 27, 2024
Heery ChristopherCHIEF MEDICAL OFFI…EXERCISE$100K–$500K25K$6.28Mar 27, 2024
Carroll JillDirectorSELL$1M+504K$70.55Mar 25, 2024
Heery ChristopherCHIEF MEDICAL OFFI…SELL$500K+10K$63.33Feb 13, 2024
Elghandour RamiSEE REMARKSSELL$1M+38K$63.33Feb 13, 2024
Heery ChristopherChief Medical Offi…SELL$100K–$500K3K$35.38Aug 7, 2023
Heery ChristopherChief Medical Offi…EXERCISE$15K–$50K3K$15.00Aug 7, 2023
🔓Seeing ranges? Sign in for exact trade values — free forever

Activist & 5%+ Owners

SC 13D/13G filings — investors holding 5%+ of outstanding shares

4.5%

2.7M shares

FMR LLC

SC 13G/A · Mar 6, 2026

0.5%

309K shares

New Enterprise Associates 15, L.P.

SC 13D/A · Feb 25, 2026

5.3%

3.0M shares

Rami Elghandour

SC 13D/A · Feb 25, 2026

6.4%

3.9M shares

Gilead Sciences, Inc.

SC 13D · Feb 23, 2026

11.5%

6.7M shares

RA Capital Management, L.P.

SC 13G/A · Feb 17, 2026

2.2%

1.3M shares

FMR LLC

SC 13G/A · Feb 5, 2026

6.2%

3.6M shares

16.6%

9.6M shares

FMR LLC

SC 13G/A · Nov 5, 2025

10.4%

5.8M shares

11.3%

6.3M shares

New Enterprise Associates 15, L.P.

SC 13D/A · Aug 15, 2025

5.5%

3.0M shares

Perceptive Advisors LLC

SC 13G/A · Aug 14, 2025

4.5%

2.5M shares

Perceptive Advisors LLC

SC 13G/A · May 15, 2025

5.3%

2.9M shares

New Enterprise Associates 15, L.P.

SC 13D/A · May 12, 2025

6.8%

3.7M shares

FMR LLC

SC 13G/A · May 12, 2025

11.5%

6.3M shares

The Vanguard Group

SC 13G/A · Apr 30, 2025

7.3%

4.0M shares

BlackRock, Inc.

SC 13G/A · Apr 17, 2025

6.4%

3.5M shares

Rami Elghandour

SC 13D/A · Feb 27, 2025

6.9%

4.0M shares

FMR LLC

SC 13G/A · Feb 12, 2025

14.7%

8.0M shares

The Vanguard Group

SC 13G · Jan 31, 2025

6.2%

3.3M shares

RA Capital Management, L.P.

SC 13G · Nov 22, 2024

5.2%

2.8M shares

Arcellx, Inc. (Subject)

SC 13G/A · Nov 14, 2024

0.0%

0 shares

Perceptive Advisors LLC

SC 13G/A · Nov 14, 2024

7.2%

3.9M shares

FMR LLC

SC 13G/A · Nov 12, 2024

12.1%

6.5M shares

Rami Elghandour 2

SC 13D · Nov 8, 2024

5.0%

2.9M shares

BlackRock, Inc.

SC 13G/A · Nov 8, 2024

7.9%

4.2M shares

BlackRock, Inc.

SC 13G/A · Oct 22, 2024

7.9%

4.2M shares

FMR LLC

SC 13G/A · Apr 10, 2024

10.2%

5.4M shares

SR One Capital Management, LLC 2

SC 13D/A · Mar 25, 2024

4.4%

2.3M shares

Arcellx, Inc. (Subject)

SC 13G/A · Feb 14, 2024

0.0%

0 shares

Perceptive Advisors LLC

SC 13G/A · Feb 14, 2024

8.8%

4.5M shares

Suvretta Capital Management, LLC

SC 13G/A · Feb 13, 2024

5.0%

2.4M shares

BlackRock, Inc.

SC 13G · Jan 29, 2024

6.2%

3.0M shares

Gilead Sciences, Inc.

SC 13G/A · Dec 28, 2023

12.9%

6.7M shares

SR One Capital Management, LLC

SC 13D/A · Dec 18, 2023

6.5%

3.1M shares

SC 13G · Jul 21, 2023

0.0%

0 shares

New Enterprise Associates 15, L.P.

SC 13D/A · Jun 23, 2023

7.8%

3.7M shares

SR One Capital Management, LLC

SC 13D/A · Jun 2, 2023

8.2%

3.9M shares

SR One Capital Management, LLC

SC 13D/A · May 19, 2023

9.3%

4.5M shares

4.7%

2.1M shares

Perceptive Advisors LLC

SC 13G · Feb 14, 2023

5.5%

2.6M shares

Suvretta Capital Management, LLC

SC 13G/A · Feb 13, 2023

5.4%

2.4M shares

New Enterprise Associates 15, L.P.

SC 13D/A · Jan 24, 2023

10.8%

4.7M shares

Novo Holdings A/S

SC 13G/A · Dec 12, 2022

4.0%

1.8M shares

Novo Holdings A/S

SC 13G/A · Nov 28, 2022

5.7%

2.5M shares

5.0%

2.2M shares

Suvretta Capital Management, LLC

SC 13G · Jun 27, 2022

5.8%

2.5M shares

SR One Capital Management, LLC

SC 13D/A · Jun 27, 2022

12.9%

5.5M shares

SR One Capital Management, LLC

SC 13D · Feb 17, 2022

15.8%

5.5M shares

19.2%

6.4M shares

View on Google Finance →